Biotech Growth N V - Oct 27, 2022 Form 4 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Role: 10%+ Owner
Signature: /s/ Ivo Betschart
Stock symbol: BDTX
Transactions as of: Oct 27, 2022
Transactions value $: $736,186
Form type: 4
Date filed: 10/31/2022, 03:20 PM
Previous filing: Oct 28, 2022
Next filing: Nov 2, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDTX	Common Stock	Purchase	$359K	+192K	+3.9%	$1.87	5.11M	Oct 27, 2022	Direct
transaction	BDTX	Common Stock	Purchase	$377K	+173K	+3.39%	$2.18	5.28M	Oct 28, 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Black Diamond Therapeutics, Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Growth N.V.